FDA advisors endorse 2nd J&J shots

Murky data fueled debate between "booster" dose or changing the one-shot J&J vaccine to a two-shot vaccination

FDA’s panel of outside experts voted 19-0 to support expanding the emergency use authorization of the Johnson & Johnson COVID-19 vaccine to include a second dose at least two months after the first dose of the one-shot vaccine.

But the decision facing the FDA isn’t as clear. More on that, including the latest on comparative efficacy of the three vaccines, below.